Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
Global Deep Brain Stimulation Devices Market, By Product Type (Dual-channel Deep Brain Stimulator, Single-channel Deep Brain Stimulator), By Type (Rechargeable, Non-Rechargeable), By Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Dystonia, Obsessive Compulsive Disorder) By End User (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others), By Region, Competition, Forecast & Opportunities, 2017- 2027
... (Hospitals, Ambulatory Surgical Centers, Neurological Clinics, Others), By Region, Competition, Forecast & Opportunities, 2017- 2027 The global deep brain stimulation devices market is expected to grow at a robust CAGR of 7.23% to reach a ... Read More
-
2022 Global Forecast for Epilepsy Monitoring Devices (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a ... Read More
-
Neuromodulation Market By Technology (Internal Neuromodulation, External Neuromodulation), By Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), By Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), : Global Opportunity Analysis and Industry Forecast, 2020-2030
... : Global Opportunity Analysis and Industry Forecast, 2020-2030 The global neuromodulation market was valued at $2,480.2 million in 2020, and is projected to reach $4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 ... Read More
-
Implantable Cardiac Monitors Market By Indication (Cardiac Arrrythmias, Atrial Fribrillation, Epilepsy And Unexplained Falls), By End User (Hospitals And Clinics, Home Settings, Ambulatory Surgical Centers (Ascs)): Global Opportunity Analysis and Industry Forecast, 2020-2030
... implantable cardiac monitors market was valued at $500.02 million in 2020, and is projected to reach $974.42 million by 2030, registering a CAGR of 7.2% from 2021 to 2030. An implantable cardiac monitor(ICM), also known ... Read More
-
Epilepsy Monitoring Devices Market
... more important market dynamics. After conducting thorough research on the historical and current growth parameters of the Epilepsy Monitoring Devices Market, the growth prospects of the market are obtained with maximum precision. Market Segmentation The ... Read More
-
Childhood Epilepsy Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2021-2027
... 27 drugs in the pipeline with 79% molecules present in early stage. Mid-sized Pharma dominates R&D in this indication. The increasing uptake of recently launched therapies will drive the market's growth, but wide availability of ... Read More
-
Global Epilepsy Monitoring Devices Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Epilepsy is a central nervous system (neurological) disorder characterized by abnormal brain activity, resulting in seizures or periods of unusual behaviour, sensations, and, in ... Read More
-
Epilepsy Monitoring Devices Market Size, Share & Trends Analysis By Product, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... million by 2030 According to SPER Market Research, the epilepsy monitoring devices market estimated to reach USD 724 million by 2030 with a CAGR of 4.5%. Epilepsy is the most common neurological disorder affecting people ... Read More
-
Neurostimulation Devices Market Size By Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation [TENS]), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027
... Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027 The neurostimulation devices market is poised to amass significant gains by 2027 on ... Read More
-
Refractory Epilepsy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Refractory Epilepsy Understanding The DelveInsight Refractory Epilepsy ... Read More
-
Drug Resistant Epilepsy - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Drug Resistant Epilepsy Understanding The ... Read More
-
Partial Epilepsy - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Partial Epilepsy Understanding The DelveInsight Partial Epilepsy ... Read More
-
Anti-Epileptic Drugs/Epilepsy - Epidemiology Forecast - 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Anti-Epileptic Drugs/Epilepsy Understanding The DelveInsight Anti-Epileptic Drugs/Epilepsy ... Read More
-
Drug-Resistant refractory epilepsy - Epidemiology Forecast - 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Drug-Resistant refractory epilepsy Understanding The ... Read More
-
Epilepsy - Epidemiology Forecast to 2032
... the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Epilepsy Understanding The DelveInsight Epilepsy epidemiology report gives a ... Read More
-
Parkinson's Disease Treatment Resistant Epilepsy - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Parkinson's ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast to 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Developmental ... Read More
-
Lennox Gastaut Syndrome - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Lennox Gastaut Syndrome Understanding The ... Read More
Research Assistance
